Benzinga Bulls and Bears: Costco, KB Home, McDonald’s
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Stocks · News reference
Guggenheim Maintains Neutral on Trade Desk, Raises Price Target to $13
Guggenheim analyst Michael Morris maintains Trade Desk (NASDAQ:TTD) with a Neutral and raises the price target from $12 to $13.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Why Is The Trade Desk Stock Falling on Wednesday?
The Trade Desk stock fell on Wednesday due to S&P 500 index deletion mechanical selling and ad-tech sector pressures from AppLovin.
Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars?
The Trade Desk (TTD) is strengthening its healthcare advertising position through a new integration with OptimizeRx (OPRX), giving advertisers access to authenticated healthcare professional inventory across 400+ EHR systems reaching ~800,000 verified HCPs. The inventory will be available via TTD's OpenPath platform in Q4 2026. This partnership complements TTD's recent expansions with Veeva Crossix and IQVIA Digital, potentially attracting more pharma and life sciences advertisers. However, TTD shares have declined 71.9% over the past year and carry a Zacks Rank #4 (Sell) rating.
Why I'm Still Not Buying The Trade Desk Stock After a 90% Drop
The Trade Desk stock has plummeted 90% to around $14, but analyst Daniel Sparks argues the low price doesn't make it a bargain. The advertising technology company is facing declining revenue guidance (down 12% YoY), slowing growth from 18% to negative territory, and weakening profits. While the company maintains strong 95%+ customer retention and $1.5 billion in cash, cost-cutting measures won't address the fundamental demand problem. Sparks won't buy until revenue guidance turns positive and demand pressures ease.